The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Clinical implications and utility of field cancerization
Open accessAbstract
Cancer begins with multiple cumulative epigenetic and genetic alterations that sequencially transform a cell, or a group of cells in a particular organ. The early genetic events might lead to clonal expansion of pre-neoplastic daughter cells in a particular tumor field. Subsequent genomic changes in some of these cells drive them towards the malignant phenotype. These transformed cells are diagnosed histopathologically as cancers owing to changes in cell morphology. Conceivably, a population of daughter cells with early genetic changes (without histopathology) remain in the organ, demonstrating the concept of field cancerization. With present technological advancement, including laser capture microdisection and high-throughput genomic technologies, carefully designed studies using appropriate control tissue will enable identification of important molecular signatures in these genetically transformed but histologically normal cells. Such tumor-specific biomarkers should have excellent clinical utility. This review examines the concept of field cancerization in several cancers and its possible utility in four areas of oncology; risk assessment, early cancer detection, monitoring of tumor progression and definition of tumor margins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slaughter, D. P., Southwick, H. W., & Smejkal, W. (1953) · Cancer · doi:10.1002/1097-0142(195309)6:5<963::aid-cncr2820060515>3.0.co;2-q · Cited by 3,545
Cancer as an evolutionary and ecological process
Merlo, L. M. F., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2013 · Cited by 1,699
Braakhuis, B. J. M., Tabor, M. P., Kummer, J. A., Leemans, C. R., & Brakenhoff, R. H. (2003) · PubMed · Cited by 1,224
Integrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2007) · Nature Genetics · doi:10.1038/ng1935 · Cited by 922
Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.158 · Cited by 758
Genetic clonal diversity predicts progression to esophageal adenocarcinoma
Maley, C. C., Galipeau, P. C., Finley, J. C., Wongsurawat, V. J., Li, X., Sanchez, C. A., Paulson, T. G., Blount, P. L., Risques, R.-A., Rabinovitch, P. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1768 · Cited by 696
Frequent clones of p53-mutated keratinocytes in normal human skin
Jonason, A. S., Kunala, S., Price, G. J., Restifo, R. J., Spinelli, H. M., Persing, J. A., Leffell, D. J., Tarone, R. E., & Brash, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14025 · Cited by 685
Surveillance, Epidemiology, and End Results Program
National Cancer Institute (2020) · Definitions · doi:10.32388/5owtl5 · Cited by 626
Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas
Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D., & Smith, H. S. (1996) · Science · doi:10.1126/science.274.5295.2057 · Cited by 582
MGMT Promoter Methylation and Field Defect in Sporadic Colorectal Cancer
Shen, L., Kondo, Y., Rosner, G. L., Xiao, L., Hernandez, N. S., Vilaythong, J., Houlihan, P. S., Krouse, R. S., Prasad, A. R., Einspahr, J. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji275 · Cited by 498
O’Shaughnessy, J., Kelloff, G. J., Gordon, G., Dannenberg, A. J., Hong, W. K., Fabian, C. J., Sigman, C. C., Bertagnolli, M. M., Stratton, S. P., Lam, S. C., et al. (2002) · PubMed · Cited by 383
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.
Eads, C. A., Lord, R. V., Kurumboor, S. K., Wickramasinghe, K. S., Skinner, M. L., Long, T. I., Peters, J. H., DeMeester, T. R., Danenberg, K. D., Danenberg, P. V., et al. (2000) · PubMed · Cited by 366
Tsao, A. S., Kim, E. S., & Hong, W. K. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.3.150 · Cited by 331
Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.
Franklin, W. A., Gazdar, A. F., Haney, J., Wistuba, I. I., La Rosa, F. G., Kennedy, T., Ritchey, D. M., & Miller, Y. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119748 · Cited by 330
Mitochondria and Cancer: Warburg Addressed
WALLACE, D. C. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.035 · Cited by 285
Wong, D. J., Paulson, T. G., Prevo, L. J., Galipeau, P. C., Longton, G., Blount, P. L., & Reid, B. J. (2001) · PubMed · Cited by 274
Mitochondrial Genome Instability and mtDNA Depletion in Human Cancers
LEE, H., YIN, P., LIN, J., WU, C., CHEN, C., WU, C., CHI, C., TAM, T., & WEI, Y. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.011 · Cited by 273
Máximo, V., Soares, P., Lima, J., Cameselle-Teijeiro, J., & Sobrinho-Simões, M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61132-7 · Cited by 271
Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer.
Tan, D., Bai, R., & Wong, L. C. (2002) · PubMed · Cited by 258
Mitochondrial mutations in early stage prostate cancer and bodily fluids
Jerónimo, C., Nomoto, S., Caballero, O. L., Usadel, H., Henrique, R., Varzim, G., Oliveira, J., Lopes, C., Fliss, M. S., & Sidransky, D. (2001) · Oncogene · doi:10.1038/sj.onc.1204646 · Cited by 226
Multiple Head and Neck Tumors Frequently Originate from a Single Preneoplastic Lesion
Tabor, M. P., Brakenhoff, R. H., Ruijter-Schippers, H. J., van der Wal, J. E., Snow, G. B., Leemans, C. R., & Braakhuis, B. J. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64266-6 · Cited by 221
Galipeau, P. C., Prevo, L. J., Sanchez, C. A., Longton, G. M., & Reid, B. J. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2087 · Cited by 214
Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue
Yan, P. S., Venkataramu, C., Ibrahim, A., Liu, J. C., Shen, R. Z., Diaz, N. M., Centeno, B., Weber, F., Leu, Y.-W., Shapiro, C. L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0467 · Cited by 207
Z'graggen, K., Rivera, J. A., Compton, C. C., Pins, M., Werner, J., Fernández-del Castillo, C., Rattner, D. W., Lewandrowski, K. B., Rustgi, A. K., & Warshaw, A. L. (1997) · Annals of Surgery · doi:10.1097/00000658-199710000-00010 · Cited by 200
p53-mutant clones and field effects in Barrett's esophagus.
Prevo, L. J., Sanchez, C. A., Galipeau, P. C., & Reid, B. J. (1999) · PubMed · Cited by 197
Maley, C. C., Galipeau, P. C., Li, X., Sanchez, C. A., Paulson, T. G., Blount, P. L., & Reid, B. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1738 · Cited by 193
T he M olecular B iology of M ucosal F ield C ancerization of the H ead and N eck
Ha, P. K., & Califano, J. A. (2003) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130301400506 · Cited by 183
Promoter Hypermethylation in Benign Breast Epithelium in Relation to Predicted Breast Cancer Risk
Lewis, C. M., Cler, L. R., Bu, D.-W., Zöchbauer‐Müller, S., Milchgrub, S., Naftalis, E. Z., Leitch, A. M., Minna, J. D., & Euhus, D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.166.11.1 · Cited by 182
Kim, M. M., Clinger, J. D., Masayesva, B. G., Ha, P. K., Zahurak, M. L., Westra, W. H., & Califano, J. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0734 · Cited by 180
Gene Promoter Methylation in Prostate Tumor–Associated Stromal Cells
Hanson, J. A., Gillespie, J. W., Grover, A., Tangrea, M. A., Chuaqui, R. F., Emmert-Buck, M. R., Tangrea, J. A., Libutti, S. K., Linehan, W. M., & Woodson, K. G. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj051 · Cited by 175
Genetically Altered Fields as Origin of Locally Recurrent Head and Neck Cancer
Tabor, M. P., Brakenhoff, R. H., Ruijter-Schippers, H. J., Kummer, J. A., Leemans, C. R., & Braakhuis, B. J. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0632 · Cited by 174
Chandran, U. R., Dhir, R., Ma, C., Michalopoulos, G., Becich, M., & Gilbertson, J. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-45 · Cited by 160
Increased Mitochondrial DNA Content in Saliva Associated with Head and Neck Cancer
Jiang, W.-W., Masayesva, B., Zahurak, M., Carvalho, A. L., Rosenbaum, E., Mambo, E., Zhou, S., Minhas, K., Benoit, N., Westra, W. H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2147 · Cited by 158
Multiple Clonal Abnormalities in the Bronchial Epithelium of Patients With Lung Cancer
Park, I., Wistuba, I. I., Maitra, A., Milchgrub, S., Virmani, A. K., Minna, J. D., & Gazdar, A. F. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1863 · Cited by 150
Kanjilal, S., Strom, S. S., Clayman, G. L., Weber, R. S., El‐Naggar, A. K., Kapur, V., Cummings, K. K., HILL, L. A., Spitz, M. R., & Kripke, M. L. (1995) · PubMed · Cited by 148
Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid
Zhu, W., Qin, W., Bradley, P., Wessel, A., Puckett, C. L., & Sauter, E. R. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh282 · Cited by 147
Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas
Izawa, T., Obara, T., Tanno, S., Mizukami, Y., Yanagawa, N., & Kohgo, Y. (2001) · Cancer · doi:10.1002/1097-0142(20011001)92:7<1807::aid-cncr1697>3.0.co;2-0 · Cited by 141
Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits?
van Oijen, M. G., & Slootweg, P. J. (2000) · PubMed · Cited by 139
The role of mitochondria in ageing and carcinogenesis
Birch-Machin, M. A. (2006) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2006.02161.x · Cited by 130
Self-citationSimon, R., Eltze, E., Schäfer, K.-L., Buerger, H., Semjonow, A., Hertle, L., Dockhorn‐Dworniczak, B., Terpe, H., & Böcker, W. (2001) · PubMed · Cited by 128
Malins, D. C., Johnson, P. M., Barker, E. A., Polissar, N. L., Wheeler, T. M., & Anderson, K. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931396100 · Cited by 123
Roesch‐Ely, M., Nees, M., Karsai, S., Ruess, A., Bogumil, R., Warnken, U. H., Schnölzer, M., Dietz, A., Plinkert, P. K., Hofele, C., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209770 · Cited by 122
Chen, J. Z., Gökden, N., Greene, G. F., Mukunyadzi, P., & Kadlubar, F. F. (2002) · PubMed · Cited by 116
Eshaghian, A., Vleugels, R. A., Canter, J. A., Mcdonald, M., Stasko, T., & Sligh, J. E. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700088 · Cited by 115
The Hydra Phenomenon of Cancer: Why Tumors Recur Locally after Microscopically Complete Resection
Höckel, M., & Dornhöfer, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3868 · Cited by 114
Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
Kelloff, G. J., Sigman, C. C., Johnson, K. M., Boone, C. W., Greenwald, P., Crowell, J. A., Hawk, E. T., & Doody, L. A. (2000) · PubMed · Cited by 114
Christensen, K. D., Estes, P. A., Oñate, S. A., Beck, C. A., Marzo, A. M. D., Altmann, M., Lieberman, B. A., John, J. S., Nordeen, S. K., & Edwards, D. P. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-11-1755 · Cited by 106
Heaphy, C. M., Bisoffi, M., Fordyce, C., Haaland, C. M., Hines, W. C., Joste, N. E., & Griffith, J. K. (2006) · International Journal of Cancer · doi:10.1002/ijc.21815 · Cited by 102
EARLY IDENTIFICATION OF INDIVIDUALS WITH PROSTATE CANCER IN NEGATIVE BIOPSIES
Dhir, R., Vietmeier, B. N., Arlotti, J. A., Acquafondata, M. B., Landsittel, D. P., MASTERSON, R., & Getzenberg, R. H. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000116545.94813.27 · Cited by 102
Alterations in the mitochondrial displacement loop in lung cancers.
Suzuki, M., Toyooka, S., Miyajima, K., Iizasa, T., Fujisawa, T., Bekele, N. B., & Gazdar, A. F. (2003) · PubMed · Cited by 100
Epigenetic events in the colorectum and in colon cancer
Grady, W. M. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330684 · Cited by 97
Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins
Kim, J., Reber, H. A., Dry, S., Elashoff, D. A., Chen, S. L., Umetani, N., Kitago, M., Hines, O. J., Kazanjian, K. K., Hiramatsu, S., et al. (2006) · Gut · doi:10.1136/gut.2005.083063 · Cited by 97
Weber, F., Xu, Y., Zhang, L., Patócs, A., Shen, L., Platzer, P., & Eng, C. (2007) · JAMA · doi:10.1001/jama.297.2.187 · Cited by 97
Mitochondrial DNA damage in non-melanoma skin cancer
Durham, S. E., Krishnan, K. J., Betts, J., & Birch‐Machin, M. A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600773 · Cited by 94
Self-citationThe emerging roles of DNA methylation in the clinical management of prostate cancer
Perry, A. S., Foley, R., Woodson, K. G., & Lawler, M. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01184 · Cited by 84
ASSOCIATION BETWEEN CANCER-FREE SURVIVAL AND TELOMERE DNA CONTENT IN PROSTATE TUMORS
Fordyce, C., Heaphy, C. M., Joste, N. E., Smith, A. Y., Hunt, W. C., & Griffith, J. K. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000143195.49685.ce · Cited by 80
EXPRESSION OF A NOVEL BIOMARKER, EPCA, IN ADENOCARCINOMAS AND PRECANCEROUS LESIONS IN THE PROSTATE
Uetsuki, H., Tsunemori, H., Taoka, R., Haba, R., Ishikawa, M., & Kakehi, Y. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000165154.41159.b1 · Cited by 77
Larson, P. S., Morenas, A. D. L., Bennett, S. R., Cupples, L. A., & Rosenberg, C. L. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64180-6 · Cited by 77
Significance of somatic mutations and content alteration of mitochondrial DNA in esophageal cancer
Tan, D., Chang, J., Liu, L., Bai, R., Wang, Y., Yeh, K., & Wong, L. C. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-93 · Cited by 74
Parr, R. L., Dakubo, G. D., Crandall, K. A., Maki, J. N., Reguly, B., Aguirre, A. A., Wittock, R., Robinson, K., Alexander, J. S., Birch‐Machin, M. A., et al. (2006) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050112 · Cited by 71
Self-citationChu, T., Shen, C., Lee, H.-S., & Liu, H.-S. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199902)24:2<127::aid-gcc5>3.0.co;2-8 · Cited by 70
Can cancer cells transform normal host cells into malignant cells?
Pathak, S., Nemeth, M., Multani, A., Thalmann, G., von Eschenbach, A., & Chung, L. W. K. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.524 · Cited by 69
Ortiz, B. H., Ailawadi, M., Colitti, C., Muto, M. G., Deavers, M. T., Silva, E. G., Berkowitz, R. S., Mok, S. C., & Gershenson, D. M. (2001) · PubMed · Cited by 68
Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism
Meierhofer, D., Mayr, J. A., Fink, K., Schmeller, N. T., Kofler, B., & Sperl, W. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602929 · Cited by 66
Development and progression of urothelial carcinoma
Kakizoe, T. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00264.x · Cited by 66
Pan, H., Califano, J. A., Ponte, J. F., Russo, A. L., Cheng, K., Thiagalingam, A., Nemani, P., Sidransky, D., & Thiagalingam, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3297 · Cited by 62
Sui, G., Zhou, S., Wang, J. C. Y., Canto, M. I., Lee, E. E., Eshleman, J. R., Montgomery, E. A., Sidransky, D., Califano, J. A., & Maitra, A. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-73 · Cited by 62
The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration
Kim, S.-K., Jang, H.-R., Kim, J., Noh, S., Song, K., Kim, S., Kim, S.-Y., Yeom, Y., Kim, N.-S., Yoo, H., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.128 · Cited by 60
Furlan, D., Carnevali, I. W., Marcomini, B., Cerutti, R., Dainese, E., Capella, C., & Riva, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2679 · Cited by 60
Denzinger, S., Mohren, K., Knuechel, R., Wild, P. J., Burger, M., Wieland, W. F., Hartmann, A., & Stoehr, R. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.10.014 · Cited by 60
Linnartz, B., Anglmayer, R., & Zanssen, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2956 · Cited by 58
Gómez‐Zaera, M., Abril, J., González, L., Aguiló, F., Condom, E., Nadal, M., & Nunes, V. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.10.012 · Cited by 57
Outer Breast Quadrants Demonstrate Increased Levels of Genomic Instability
Ellsworth, D. L., Ellsworth, R. E., Love, B., Deyarmin, B., Lubert, S. M., Mittal, V., Hooke, J. A., & Shriver, C. D. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.03.024 · Cited by 57
Jiang, W.-W., Rosenbaum, E., Mambo, E., ZAHURAK, M. L., Masayesva, B. G., Carvalho, A. L., Zhou, S., Westra, W. H., Alberg, A. J., Sidransky, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1471 · Cited by 56
Malins, D. C., Gilman, N. K., Green, V. M., Wheeler, T. M., Barker, E. A., & Anderson, K. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509630102 · Cited by 54
Rosenthal, A. N., Ryan, A., Hopster, D. J., & Jacobs, I. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10362 · Cited by 53
Wang, J., Wang, Y.-H., Jao, S., Lu, C.-Y., Kuo, C., Hu, H., Hsieh, J., Chong, I., Cheng, T., & Lin, S. (2006) · Oncology Reports · doi:10.3892/or.16.6.1245 · Cited by 43
Loss of Heterozygosity in Benign Breast Epithelium in Relation to Breast Cancer Risk
Euhus, D., Cler, L. R., Shivapurkar, N., Milchgrub, S., Peters, G. N., Leitch, A. M., Heda, S., & Gazdar, A. F. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.858 · Cited by 40
Using tissue adjacent to carcinoma as a normal control: an obvious but questionable practice
Braakhuis, B. J. M., Leemans, C. R., & Brakenhoff, R. H. (2004) · The Journal of Pathology · doi:10.1002/path.1549 · Cited by 35
Shieh, D., Chou, W. P., Wei, Y., WONG, T., & Jin, Y. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1293.016 · Cited by 33
Stemke‐Hale, K., Hennessy, B. T., Mills, G. B., & Mitra, R. (2006) · Current Oncology Reports · doi:10.1007/s11912-006-0078-5 · Cited by 11
Cited by
The molecular biology of head and neck cancer
Leemans, C. R., Braakhuis, B. J. M., & Brakenhoff, R. H. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2982 · Cited by 2,524
Argiris, A., Karamouzis, M. V., Raben, D., & Ferris, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60728-x · Cited by 2,224
Molecular aspects of skin ageing
Naylor, E. C., Watson, R. E. B., & Sherratt, M. J. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.04.011 · Cited by 567
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Colonic crypt organization and tumorigenesis
Humphries, A., & Wright, N. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2392 · Cited by 334
Metadata
- Authors
- Dakubo, G. D., Jakupciak, J. P., Birch-Machin, M. A., & Parr, R. L.
- Venue
- Cancer Cell International
- Published
- 2007
- Volume
- 7
- Issue
- 1
- Pages
- 2
- ISSN
- 1475-2867 (ISSN-L)
- OpenAlex
- W2111808908
- Cited by
- 294
- References
- 81
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.